Infection Rate of a Prolonged Sacral Neuromodulation Test: A Large Retrospective Study.

Objectives: It is estimated that 3.8% to 12.5% of patients develop a device infection during the two to four weeks of the sacral neuromodulation (SNM) test, leading to removal of the entire system.

Removal of sacral neuromodulation quadripolar tined-lead using a straight stylet: description of a surgical technique.

Background: Up to 7.5% of tined-lead removals in patients having sacral neuromodulation (SNM) therapy are associated with a lead breakage. It is still unclear what adverse effects can be caused by unretrieved fragments.

Do you really want to deactivate your sacral neuromodulation device during pregnancy? A single center case series.

Introduction And Hypothesis: The main objective of the study is to assess the efficacy and safety of sacral neuromodulation (SNM) during pregnancy.

Methods: We retrospectively enrolled patients who underwent SNM implantation in our center and subsequently became pregnant. The indication for SNM, timing of device de-activation (if performed), course of pregnancy and urological complications, duration of labor, childbirth term, delivery mode, congenital abnormalities and SNM dysfunctions after delivery were recorded.

Sacral neuromodulation to treat voiding dysfunction in patients with previous pelvic surgery for deep infiltrating endometriosis: our centre's experience.

Introduction And Hypothesis: Voiding symptoms/dysfunctions (VS/Ds) after surgery for deep-infiltrating endometriosis (DIE) are frequent (20% of patients) and, together with bowel dysfunctions, may represent a de novo disorder due to surgical damage of the pelvic plexus or a worsening of pre-existent functional damage. Sacral neuromodulation (SNM) might improve voiding symptoms by treating dysfunctional voiding. The aim of this study is to report our experience with SNM in patients treated with surgery for DIE.

Detrusor acontractility in urinary retention: detrusor contractility test as exclusion criteria for sacral neurostimulation.

Purpose: Results of sacral neurostimulation in urinary retention are reported in the literature without distinction between the 2 functional disorders causing this condition, detrusor acontractility and functional outlet obstruction. We have suggested a stimulation test to differentiate irreversible bladder myopathy (or complete neurogenic lesion) from potential bladder contractility eligible for sacral neurostimulation.

Materials And Methods: Direct electrostimulation of the sacral nerves was performed with the patient under general anesthesia.

Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome.

Purpose: We investigated the impact of sacral neuromodulation on quality of life and assessed the importance of quality of life for determining the success of sacral neuromodulation in patients with detrusor hyperactivity, including instability and hyperreflexia. We also compared it with parameters documented in a voiding diary.

Materials And Methods: From May 1998 to December 2000, 82 female and 31 male patients 17 to 79 years old (mean age 51.

Neuromodulation for fecal incontinence: outcome in 16 patients with definitive implant. The initial Italian Sacral Neurostimulation Group (GINS) experience.

Purpose: Sacral nerve modulation appears to offer a valid treatment option for some patients with fecal incontinence and functional defects of the internal anal sphincter or of the striated muscle.

Methods: Sixteen patients with fecal incontinence (4 males; mean age, 51.4 (range, 27-79) years) with intact or surgically repaired (n = 1) anal sphincter underwent permanent sacral nerve stimulation implant.

Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register.

Purpose: The Italian Register was created in February 1997 to collect the national results of sacral neuromodulation. All Italian centers at which sacral neuromodulation is performed were invited to participate in our study. We present the results from retrospective and prospective registers.

Mutual influence between vesicourethral and anorectal function in spinal cord injury patients.

There is clinical evidence of a relationship between urethrovesical and anorectal dysfunction in spinal cord injured patients. This study was performed to assess how rectal distension could influence the results of urodynamic investigations. Ten patients with spinal cord injury were submitted to repeated urodynamic evaluations under different rectal conditions after performing complete anorectal testing.

Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients.

The effect of cisapride on constipation in para and tetraplegia is well known. We have investigated the effects of this prokinetic drug on anorectal activity and on the function of the lower urinary tract. One result of the anorectal study showed a significant increase in activity and a reduction in compliance of the ampulla.